Clinical Trial

The REACT Study: REhabilitation and ACTivity in Allogenic Transplant

Study acronym: REACT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, longitudinal cohort study will be conducted to evaluate the effects of treatment on the physical function of patients undergoing Allogeneic Hematopoeitic Stem Cell Transplant.
Trial Details
NCT Number NCT07581093
Lead Sponsor University of Dublin, Trinity College
Collaborators: Health Research Board, Ireland
Conditions Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)
Enrollment 140 participants
Start Date 2026-05-01
Primary Completion 2029-12-28 (estimated)
Study Completion 2029-12-28 (estimated)
Updated on ClinicalTrials.gov 2026-05-12